BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 5675206)

  • 1. Raynaud's phenomenon as leading sign in lupus erythrmatosus--report of three cases and classification of cryopathies.
    Kenamore BD; Levin WC; Ritzmann SE
    Tex Rep Biol Med; 1968; 26(2):189-97. PubMed ID: 5675206
    [No Abstract]   [Full Text] [Related]  

  • 2. Raynaud's phenomenon in systemic lupus erythematosus.
    Lavras Costallat LT; Valente Coimbra AM
    Rev Rhum Engl Ed; 1995 May; 62(5):349-53. PubMed ID: 7655867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnostic value of thermography in Raynaud's phenomenon associated with systemic lupus erythematosus].
    Mikulska D
    Ann Acad Med Stetin; 2009; 55(3):23-7. PubMed ID: 20698174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Raynaud's syndrome in systemic lupus erythematosus and rheumatoid arthritis].
    Balaban SIa; Erov NK
    Revmatologiia (Mosk); 1986; (1):29-32. PubMed ID: 3520764
    [No Abstract]   [Full Text] [Related]  

  • 5. [Acrocyanosis, Raynaud's phenomenon and digital gangrene in a case of systemic lupus erythematosus].
    Montuori R; Riccardi C
    Minerva Med; 1968 Feb; 59(10):515-21. PubMed ID: 5642234
    [No Abstract]   [Full Text] [Related]  

  • 6. Raynaud's phenomenon with oral manifestation in systemic lupus erythematosus.
    da Cunha Bang F; Lange Wantzin G; Dahl Christensen J
    Dermatologica; 1985; 170(5):263-4. PubMed ID: 4007223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic algorithm for Raynaud's phenomenon and vascular skin lesions in systemic lupus erythematosus.
    Richter JG; Sander O; Schneider M; Klein-Weigel P
    Lupus; 2010 Aug; 19(9):1087-95. PubMed ID: 20693202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Case of SLE presenting primary symptoms of Raynaud's phenomenon and pulmonary heart].
    Tanaka S; Fukase M; Tsunamatsu T; Sugai S; Kurihara J
    Nihon Rinsho; 1968 Dec; 26(12):3478-84. PubMed ID: 5753028
    [No Abstract]   [Full Text] [Related]  

  • 9. Raynaud's syndrome: diagnosis and management.
    Birnstingl M
    Br J Hosp Med; 1979 Jun; 21(6):602-6, 611. PubMed ID: 476333
    [No Abstract]   [Full Text] [Related]  

  • 10. Systemic autoimmune disease and Raynaud's phenomenon: a common, immunologically mediated, vascular basis?
    Kallenberg CG; Wouda AA; The TH
    Neth J Med; 1984; 27(9):322-6. PubMed ID: 6334812
    [No Abstract]   [Full Text] [Related]  

  • 11. Electroacupuncture therapy for arthralgia and Raynaud's phenomenon in a patient with systemic lupus erythematosus.
    Donoyama N; Ohkoshi N
    Acupunct Med; 2010 Mar; 28(1):49-51. PubMed ID: 20351379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe Raynaud's phenomenon in a patient with antinuclear antibody-negative systemic lupus erythematosus.
    Maxwell CJ; Potter E; Townsend J
    J Natl Med Assoc; 1988 May; 80(5):594-5. PubMed ID: 3262169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Calcium antagonists and Raynaud's phenomenon].
    Hachulla E; Devulder B
    Therapie; 1993; 48 Spec No():707-11. PubMed ID: 8091357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical significance of Raynaud's phenomenon in systemic lupus erythematosus.
    Dimant J; Ginzler E; Schlesinger M; Sterba G; Diamond H; Kaplan D; Weiner M
    Arthritis Rheum; 1979 Aug; 22(8):815-9. PubMed ID: 465096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dermatology and internal medicine from the view of vascular surgery--collagenic Raynaud's syndrome].
    Tsunekawa K; Yamamoto K; Moori K; Hirooka M; Ikeda M
    Saishin Igaku; 1966 Oct; 21(10):2156-63. PubMed ID: 5977765
    [No Abstract]   [Full Text] [Related]  

  • 16. Pulmonary hypertension in systemic lupus erythematosus: a report of four cases.
    Hodson P; Klemp P; Meyers OL
    Clin Exp Rheumatol; 1983; 1(3):241-5. PubMed ID: 6681141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thermographic assessment of Raynaud's phenomenon in childhood mixed connective tissue disease].
    Yokota S; Kuriyama T; Takahashi Y; Mori M; Shike H; Ibe M; Mitsuda T; Aihara Y
    Ryumachi; 1994 Dec; 34(6):955-60. PubMed ID: 7863385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sarpogrelate hydrochloride for Raynaud's phenomenon of patients with collagen diseases].
    Kumagai S; Morinobu A; Ozaki S; Nakao K; Ishida H
    Ryumachi; 1998 Jun; 38(3):504-10. PubMed ID: 9721558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mucocutaneous lesions in patients with systemic lupus erythematosus].
    Saurit V; Campana R; Ruiz Lascano A; Ducasse C; Bertoli A; Agüero S; Alvarellos A; Caeiro F
    Medicina (B Aires); 2003; 63(4):283-7. PubMed ID: 14518140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Controlled study of nifedipine in the treatment of Raynaud's phenomenon].
    Kahan A; Weber S; Amor B; Saporta L; Hodara M; Degeorges M
    Rev Rhum Mal Osteoartic; 1982 Apr; 49(5):337-43. PubMed ID: 6285445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.